| Apr 15, 2014
| 12:00 PM
It was interesting to read that there is now a cure for hepatitis C in the form of new drugs that are capable of completely suppressing the virus in 90 percent of patients in 8 to 12 weeks ("Gilead Sciences' $84,000 price for hepatitis drug is...
| Aug 15, 2014
| 8:21 AM
(Reuters) - Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent.
The mid-stage trial tested Achillion's...
| Aug 14, 2014
| 4:40 PM
LONDON (Reuters) - Gilead Sciences' expensive new hepatitis C pill has been endorsed for use in certain patients by Britain's healthcare cost-effectiveness watchdog, after the U.S. firm provided more information.
The National Institute for Health and...
| Aug 13, 2014
| 11:45 AM
(Reuters) - Vertex Pharmaceuticals Inc is stopping U.S. sales and distribution of its Incivek hepatitis C treatment, whose use has been largely supplanted by the new Sovaldi drug from Gilead Sciences Inc.
On Monday, Vertex sent a letter to doctors who...
| Jul 6, 2014
| 4:55 PM
Randy Gutzke, a longtime IV drug user who says he struggles daily to stay sober, recently was offered a quick-results test for hepatitis C at a West Side community health center.
A case manager also reviewed the behaviors that put him at risk for...
| Jul 11, 2014
| 12:20 PM
Two U.S. senators asked Gilead Sciences Inc. to produce documents explaining why its new hepatitis C drug is priced at $84,000 per treatment course, raising renewed concerns over the high costs to taxpayers.
In a letter sent Friday, Ron Wyden (D-Ore.)...
| Jul 21, 2014
| 6:00 AM
It’s hard to imagine a more challenging time in Bon Temps as the town struggles to recover from vampire attacks, vigilantism and the deadly hepatitis V virus.
Exhausted Sookie Stackhouse (Anna Paquin) wants to mourn the dead alone, but her friends...
| May 28, 2014
| 2:30 AM
Harvard Health Blog
If you're a baby boomer, the U.S. Centers for Disease Control and Prevention (CDC) recommends that you be tested for infection with the hepatitis C virus. The virus can live in the liver for decades, often causing silent damage that...
| Jun 13, 2014
| 2:42 PM
U.S. regulators have granted priority review for AbbVie Inc's experimental all-oral regimen for patients infected with the most common genotype of hepatitis C virus, the company said on Friday.
The priority review means the Food and Drug...
| Jun 28, 2014
| 6:05 PM
Egypt’s military on Saturday pressed ahead with promotion of a fanciful device it claims can diagnose and cure AIDS and hepatitis, announcing that it would be tested in the next six months on larger numbers of patients in army hospitals.
| Apr 24, 2014
| 1:00 PM
How much are childhood vaccines worth to America? Nearly $1.7 trillion, according to the Centers for Disease Control and Prevention.
That dollar figure represents the net savings of 20 years’ worth of vaccines administered to American children...
| Apr 25, 2014
| 10:04 AM
AbbVie Inc. posted better-than-expected first-quarter earnings on Friday, propelled by another strong quarter of sales of the blockbuster drug Humira.
The North Chicago-based pharmaceutical company said Friday that revenue rose 5.4 percent to $4.56...